Advair Diskus 250/50 is also indicated to reduce exacerbations in patients with a history of exacerbations. Advair Diskus 250/50 is the only approved strength for COPD because an efficacy advantage of ...
Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg, 115mcg/21mcg, 230mcg/21mcg; per inh; metered-dose inhaler; CFC-free. Store at room temperature between 68° F and 77° F (20° C and 25° C) ...
GlaxoSmithKline’s respiratory blockbuster Advair may have once been a top target for generics, but now Novartis is backing out of its copycat program—and paying a hefty price. It's not just a blow to ...
LONDON, June 10 (Reuters) - Generic companies hoping to market a cheap copy of GlaxoSmithKline's best-selling inhaled lung drug Advair might have wait until 2012 before winning a green light from ...
LONDON, Feb 18 (Reuters) - GlaxoSmithKline will battle to defend a key patent next week on its top drug in Germany, Europe's biggest market, in a court case highlighting the worldwide generic threat ...
US FDA approves Lannett's generic Advair inhaler version: Respirent Pharmaceuticals and Lannett have received final approval from the US Food and Drug Administration (FDA) for a generic version of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results